Navigation Links
NutraCea Announces Third Quarter 2008 Financial Results
Date:11/7/2008

el subsidiary. SG&A expenses for our Irgovel subsidiary consist of marketing, selling, and administrative expenses.

Brad Edson, President and CEO of NutraCea stated, "We are moving ahead with our China facility and it is anticipated to be over seven times the size of our existing facility in Brazil. This project will incorporate state of the art technology and because of scale is anticipated to generate results that are more than seven times greater than what we are currently achieving in Brazil. This project is progressing and we hope to obtain all the necessary permits and approvals shortly and break ground in the first quarter of 2009.

The Company is closing in on being able to realize some of the benefits of the tremendous amount of effort it has applied towards stabilizing Wheat Bran. We are moving closer to realizing the benefits of these efforts and we believe we are about a year ahead of schedule of deploying this technology into the marketplace. This offers tremendous upside to the company without requiring a corresponding burden of capital. Additionally the Company is finalizing details to further extract incremental value from our Stabilized Rice Bran within the United States with certain initiatives that are now underway. Both of these items will be more fully discussed on the conference call.

"We are proud of the results achieved during the past year and our ability to expand our presence and produce healthy revenue gains. We have built a stronger, more balanced company, and given our global position and recently enhanced financial condition are nicely positioned to leverage the capacity that we have now built. We believe the Company is now close to an inflection point, where our capacity and the ability to utilize it should allow sufficient revenue to be able to be produced to move it into sustained profitability. We continue to proceed into the fourth quarter with expectations for increased top line growth, and continued improveme
'/>"/>

SOURCE NutraCea
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. NutraCea Announces Third Quarter 2008 Conference Call
2. Mike Bridges Takes Home Four Gold Medals at IPF Masters World Powerlifting Championships; Says NutraCeas RiSolubles(R) is an Essential Part of his Training Regimen
3. U.S. Chamber Recognizes NutraCea for Strong Corporate Stewardship
4. NutraCea Announces First Quarter 2008 Financial Results
5. NutraCea to Host First Quarter 2008 Conference Call on May 12.
6. NutraCea Announces $20 Million Securities Offering
7. Demand for NutraCea Rice Bran Oil Prompts Major Expansion of Irgovel Plant Ahead of Schedule
8. NutraCea-Sponsored Study Demonstrates Benefits of Replacing Wheat Flour with Stabilized Rice Bran (SRB) in Battered and Fried Product Applications
9. NutraCea Appoints New Chief Financial Officer
10. New World Record Holder in Powerlifting Credits NutraCeas Unique Rice-Bran-derived Product as his Secret Weapon
11. NutraCea to Purchase Largest Rice Bran Oil Processing Facility in South America

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... grew out of a collaboration between UCLA engineer...he nearly 10 million Americans who suffer from per...rdening of the arteries, peripheral arterial disea...ch narrowed arteries reduce blood flow to the limb...ular disease, heart attack and stroke, and its pro...
(Date:11/25/2009)...too short to draw definite conclusions, experts sa...ws) -- In diabetic patients with blocked coronary ...comes at one year whether patients undergo bypass ...archers report. , Bypass surgery has been the s...ary artery disease. However, less invasive approac...
(Date:11/25/2009)...ation and treatment clinics to resume Monday, Nov....ovember 25, 2009 -- Centegra Health System is cont...ne shots at four Centegra Primary Care (CPC) vacci...as arrived. The clinics are at CPC sites in Huntle... open as follows: ,   From 4:30 to 7:3...
(Date:11/25/2009)...ological symptoms, study finds , , WEDN...de effects are among the potential problems faced ...re treated with cisplatin-based chemotherapy, a ne...orwegian men treated for unilateral testicular can...w-up survey conducted from 1998 to 2002. , The ...
(Date:11/25/2009)...re/-- MISSIONSkincare ®isproudtosupportGNC,se...NC,sannualSt.Jude ThanksandGiving campaign,$1fromt...ER-C(TM)LipBalm willbedonatedtoSt.Jude.Additionall...onationatcheckoutatoneoftheir5,000+retaillocations...Judeduringtheir2009 ThanksandGiving campaign. ,...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2
...y, contrast-enhanced sonography compared with sono...sessment of blunt abdominal trauma.// Massimo... objective of our study was to prospectively compa...ts”. The study was conducted by the departme...
...d about subject as sex is, perhaps vying with each...act of stress is well known - responsible //for ma...ecently stress during pregnancy was thought to lea...en seem to be twice inclined to suffer PSTD and de...
...ced that the deadly H5N1 strain of bird flu has be...ria, which is the first African// country to be hi...been reported, experts fear that several cases hav...es in Taraba, one commercial farm and two places w...
...c study says ‘significant fluctuations in the firs...ncreases// the chances of death’. According to...ying diastolic blood pressure, which again is root...24 hours. Blood pressures were checked every five ...
...nt of Energy's Pacific Northwest National Laborato...s that the damage in neurodegenerative diseases// ...led nitration. It was explained that Parkinson's, ...idative stress, the cell damage that is usually ca...
...els will sashay down the catwalk alongside eight b...s Assam city// . Preparations are on for the ...e ornate Pragjyoti cultural centre in Guwahati. Yo...ippanita Sharma for company that day. "The e...
Other Medicine News:Health News:New Tool Found to be Effective in Assessing Blunt Abdominal Trauma 2Health News:Fluctuating BP and Stroke Lowered Patient Survival Rate 2Health News:Scientist Optimistic In Breakthrough For Causes Of Neurodegenerative Diseases 2Health News:Blind Girl Students to Catwalk in Guwahati Fashion Show 2
(Date:11/25/2009)...--RegadoBiosciences,aprivatelyheldcompanyleadingth...rolagents,announcedthatDavidMazzo,PhD,CEOandPresid...lthCareConferenceattheNewYorkPalaceHotelinNewYorkC...onTuesday,December1andwillincludeanoverviewoftheCo...gram,theanticoagulantsystem,REG1.Thehealthcareindu...
(Date:11/25/2009).../--SwissrayInternational,Inc.aleadingmanufacturero...odaythatitsoperationshavebeenacquiredbyaprivateSwi...smedicalimagingbrand.Theacquisitionincludedallasse...ntory.After25yearsofsuccessandgrowthSwissrayisnowp...tswithstableandsteadygrowth. ,, "Swissrayhaslon...
(Date:11/25/2009)...nker.comannouncesthatanewmarketresearchreportisava...y-USMarketTrends&Analysis http://www.reportli...rket-Trends--Analysis.html ,, TheUSintranasald...ticapplicationsfromthedeliveryofconventionallocalt...rugs.Thefutureofthetechnologyhingesontotheeffectiv...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Gamida Cell and Cellerix Partner on Feasibility Study 14558 1Gamida Cell and Cellerix Partner on Feasibility Study 14558 2Gamida Cell and Cellerix Partner on Feasibility Study 14558 3NASCSA Receives 24200 000 Grant From Purdue Pharma L P to Support State Prescription Drug Monitoring Programs 5633 1NASCSA Receives 24200 000 Grant From Purdue Pharma L P to Support State Prescription Drug Monitoring Programs 5633 2Shire Targets Fourth Quarter Filing of BLA for REPLAGAL 28R 29 for Fabry Disease With U S FDA 5629 1Shire Targets Fourth Quarter Filing of BLA for REPLAGAL 28R 29 for Fabry Disease With U S FDA 5629 2Shire Targets Fourth Quarter Filing of BLA for REPLAGAL 28R 29 for Fabry Disease With U S FDA 5629 3Shire Targets Fourth Quarter Filing of BLA for REPLAGAL 28R 29 for Fabry Disease With U S FDA 5629 4
...ed Parenteral Product Ganite(R), BERKELEY HEIGHTS...A ) today announced that the Company has received ...pharmaceutical gallium compositions,and complexes ... U.S.,Patent 7,354,952 extends the intellectual pr... gallium-containing products that are intended,as ...
...R Annual Meeting, SOMERSET, N.J., April 14 Alfac...hat Dr. Intae Lee with the University of,Pennsylva...ase) could be a,promising radiation sensitizer for...clinical in vivo and in vitro data in a poster at ...AACR) Annual Meeting being held April 12 -,16 in S...
Other Medicine Technology:Genta Receives Key Patent Related to Oral Gallium Compound G4544 2Genta Receives Key Patent Related to Oral Gallium Compound G4544 3Alfacell's ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment 2Alfacell's ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment 3
Pediatric Ureteral Catheters
Silicone Universal Drainage Stents
Double Pigtail Stent Sets - Polyurethane
Koyle Diaper Stents
Medicine Products: